| Distinct acute effects of LSD, MDMA, and d-amphetamine in healthy subjects F Holze, P Vizeli, F Müller, L Ley, R Duerig, N Varghese, A Eckert, ... Neuropsychopharmacology 45 (3), 462-471, 2020 | 237 | 2020 |
| Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects F Holze, P Vizeli, L Ley, F Müller, P Dolder, M Stocker, U Duthaler, ... Neuropsychopharmacology 46 (3), 537-544, 2021 | 212 | 2021 |
| Lysergic acid diethylamide–assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study F Holze, P Gasser, F Müller, PC Dolder, ME Liechti Biological Psychiatry 93 (3), 215-223, 2023 | 198 | 2023 |
| Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects F Holze, L Ley, F Müller, AM Becker, I Straumann, P Vizeli, SS Kuehne, ... Neuropsychopharmacology 47 (6), 1180-1187, 2022 | 157 | 2022 |
| Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double‐blind, placebo‐controlled, crossover study in healthy subjects AM Becker, F Holze, T Grandinetti, A Klaiber, VE Toedtli, KE Kolaczynska, ... Clinical Pharmacology & Therapeutics 111 (4), 886-895, 2022 | 140 | 2022 |
| Low doses of LSD acutely increase BDNF blood plasma levels in healthy volunteers NRPW Hutten, NL Mason, PC Dolder, EL Theunissen, F Holze, ME Liechti, ... ACS pharmacology & translational science 4 (2), 461-466, 2020 | 126 | 2020 |
| Mood and cognition after administration of low LSD doses in healthy volunteers: A placebo controlled dose-effect finding study NRPW Hutten, NL Mason, PC Dolder, EL Theunissen, F Holze, ME Liechti, ... European Neuropsychopharmacology 41, 81-91, 2020 | 116 | 2020 |
| A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers JG Ramaekers, N Hutten, NL Mason, P Dolder, EL Theunissen, F Holze, ... Journal of Psychopharmacology 35 (4), 398-405, 2021 | 89 | 2021 |
| Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects F Holze, U Duthaler, P Vizeli, F Müller, S Borgwardt, ME Liechti British journal of clinical pharmacology 85 (7), 1474-1483, 2019 | 84 | 2019 |
| Alcohol acutely enhances decoding of positive emotions and emotional concern for positive stimuli and facilitates the viewing of sexual images PC Dolder, F Holze, E Liakoni, S Harder, Y Schmid, ME Liechti Psychopharmacology 234, 41-51, 2017 | 70 | 2017 |
| Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants L Ley, F Holze, D Arikci, AM Becker, I Straumann, A Klaiber, F Coviello, ... Neuropsychopharmacology 48 (11), 1659-1667, 2023 | 66 | 2023 |
| Ketanserin reverses the acute response to LSD in a randomized, double-blind, placebo-controlled, crossover study in healthy participants AM Becker, A Klaiber, F Holze, I Istampoulouoglou, U Duthaler, ... International Journal of Neuropsychopharmacology 26 (2), 97-106, 2023 | 66 | 2023 |
| Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants F Müller, E Kraus, F Holze, A Becker, L Ley, Y Schmid, P Vizeli, ME Liechti, ... Psychopharmacology 239 (6), 1933-1943, 2022 | 55 | 2022 |
| Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants SB Vogt, L Ley, L Erne, I Straumann, AM Becker, A Klaiber, F Holze, ... Translational Psychiatry 13 (1), 172, 2023 | 54 | 2023 |
| Role of the 5-HT2A Receptor in Acute Effects of LSD on Empathy and Circulating Oxytocin F Holze, I Avedisian, N Varghese, A Eckert, ME Liechti Frontiers in Pharmacology 12, 711255, 2021 | 54 | 2021 |
| Pharmacokinetics and pharmacodynamics of lysergic acid diethylamide microdoses in healthy participants F Holze, ME Liechti, NRPW Hutten, NL Mason, PC Dolder, EL Theunissen, ... Clinical Pharmacology & Therapeutics 109 (3), 658-666, 2021 | 50 | 2021 |
| Pharmacokinetics and pharmacodynamics of oral psilocybin administration in healthy participants F Holze, AM Becker, KE Kolaczynska, U Duthaler, ME Liechti Clinical Pharmacology & Therapeutics 113 (4), 822-831, 2023 | 47 | 2023 |
| Safety pharmacology of acute LSD administration in healthy subjects F Holze, TV Caluori, P Vizeli, ME Liechti Psychopharmacology, 1-13, 2022 | 42 | 2022 |
| Characterizing thalamocortical (dys) connectivity following d-amphetamine, LSD, and MDMA administration M Avram, F Müller, H Rogg, A Korda, C Andreou, F Holze, P Vizeli, L Ley, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 7 (9), 885-894, 2022 | 37 | 2022 |
| MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens F Müller, F Holze, P Dolder, L Ley, P Vizeli, A Soltermann, ME Liechti, ... Neuropsychopharmacology 46 (3), 545-553, 2021 | 37 | 2021 |
Patrick Vizeli, PhDPostdoc, University of California San Diego & University of BaselVerified email at unibas.ch